CD83 and neoplasm: Analysis of our scRNA-seq dataset using 130 previously published immune gene sets revealed that the CD83 tumor expression signature demonstrated a robust, positive correlation with CD8+ T cell– and T cell–activating cytokine gene sets (Fig. 3E; refs. 39, 40).